These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15052816)

  • 21. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
    Woolcock A; Lundback B; Ringdal N; Jacques LA
    Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Fowler SJ; Lipworth BJ
    JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665
    [No Abstract]   [Full Text] [Related]  

  • 23. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Miller FG; Shorr AF
    JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bronchial asthma as an inflammation and the use of inhaled steroid].
    Kaneko F; Akiyama K
    Nihon Rinsho; 1996 Nov; 54(11):2962-8. PubMed ID: 8950938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Friedman Ross L
    JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
    [No Abstract]   [Full Text] [Related]  

  • 26. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
    JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
    [No Abstract]   [Full Text] [Related]  

  • 27. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D; Bacci E; Dente FL; Di Franco A; Vagaggini B; Testi R; Paggiaro P
    Chest; 1999 Mar; 115(3):629-34. PubMed ID: 10084467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluticasone propionate/salmeterol combination.
    Lipworth BJ
    J Allergy Clin Immunol; 2001 Apr; 107(4):746. PubMed ID: 11295673
    [No Abstract]   [Full Text] [Related]  

  • 30. Seretide meta-analysis missed important features and overstates any advantages over concurrent LABA/ICS devices.
    Metcalfe S; Moodie P
    J Allergy Clin Immunol; 2004 Mar; 113(3):568-9; author reply 569-71. PubMed ID: 15007365
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety Study of Salmeterol in Asthma in Adults.
    Wilsdon T; Kichenadasse G; Rowland A
    N Engl J Med; 2016 Sep; 375(11):1096-7. PubMed ID: 27626532
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety Study of Salmeterol in Asthma in Adults.
    Hasegawa T; Uno H; Wei LJ
    N Engl J Med; 2016 Sep; 375(11):1097. PubMed ID: 27626533
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety Study of Salmeterol in Asthma in Adults.
    Weinberger M
    N Engl J Med; 2016 Sep; 375(11):1097-8. PubMed ID: 27626534
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety Study of Salmeterol in Asthma in Adults.
    Stempel DA; Yeakey AM; Pascoe SJ
    N Engl J Med; 2016 Sep; 375(11):1098. PubMed ID: 27626531
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma.
    Lee DK; Currie GP; Lipworth BJ
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):410-1; author reply 411-2. PubMed ID: 15801257
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.
    Angus R; Reagon R; Cheesbrough A
    Int J Clin Pract; 2005 Feb; 59(2):156-62. PubMed ID: 15854190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Control of asthma by treatment with inhaled corticosteroids and prolonged action beta 2-agonists in free or fixed combination. Results of the ALISE study].
    Serrier P; Roche N; Pello JY; Larguier JS; Mezzi K
    Presse Med; 2003 Mar; 32(11):493-7. PubMed ID: 12733387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta 2 agonists and the course of bronchial asthma].
    Chazan R; Droszcz W
    Pol Arch Med Wewn; 1992; 87(4-5):285-8. PubMed ID: 1355903
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.